Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Best Practice & Research. Clinical Endocrinology & Metabolism|June 15, 2010
Holistic management of DSDCaroline E Brain, Sarah M Creighton, Imran Mushtaq, et al.
Pharmaceutics|November 26, 2022
Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical CharacteristicsAlexander J Plant-Hately, Burcu Eryilmaz, Christopher A W David, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 23, 2022
Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1Bethany J Heaton, Rebecca L Jensen, James Line, et al.
Clinical Endocrinology|April 1, 1989
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatinP C Hindmarsh, D R Matthews, C E Brain, et al.
Breast (Edinburgh, Scotland)|November 26, 2020
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancerB Porte, M Carton, F Lerebours, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patientsP Soulié, C Garrino, M A Bensmaïne, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directionsS B Schagen, M Klein, J C Reijneveld, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancerP Soulié, A Bensmaïne, C Garrino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancerI Monnet, P Soulié, H de Cremoux, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2007
Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumoursH Bourgeois, J Vermorken, G Dark, et al.
Pageof 11